A medical expert discusses the findings of a randomized trial investigating the use of andexanet alfa versus usual care in patients with acute intracerebral hemorrhage (ICH) and recent direct oral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback